
About Orbit Pharma Laboratories LLP
Data last updated:
Orbit Pharma Laboratories LLP was a limited liability partnership (LLP) based in Kalol, Gujarat, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2020.
The LLP was registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAU-4237.
The LLP had a total obligation of contribution of ₹10 Lakh. It was led by designated partners including Naranbhai Parshotambhai Kikani and Rima Kunal Kikani.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office was at Block No. 155/1 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729.
The LLP has about 35 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹11.71 Cr and satisfied charges of ₹17.5 Lakh on record. Court records list 10 cases involving the LLP, including 10 filed against it.
The last known website on record is orbitpharm.com.
Company details
Contact details
Orbit Pharma Laboratories LLP's registered office is in Kalol, Gujarat.
- Registered AddressBlock No. 155/1 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Orbit Pharma Laboratories LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Orbit Pharma Laboratories LLP, buy the company report.
Designated partners of Orbit Pharma Laboratories LLP
Orbit Pharma Laboratories has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naranbhai Parshotambhai Kikani Also directs: Orbit Pharma Laboratories Limited | Designated Partner | 26 Oct 2020 | 6 Years 0 Months | As last reported |
| Rima Kunal Kikani Also directs: Orbit Pharma Laboratories Limited, Khwaish Organics LLP | Partner | 10 Apr 2024 | 2 Years 6 Months | As last reported |
| Kunal Naranbhai Kikani Also directs: Orbit Pharma Laboratories Limited, Khwaish Organics LLP | Designated Partner | 01 Sep 2022 | 4 Years 1 Months | As last reported |
| Smitaben Naranbhai Kikani Also directs: Orbit Pharma Laboratories Limited | Partner | 26 Oct 2020 | 6 Years 0 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2022 | L-100633814 | Bank of Maharashtra | ₹2.11 Cr | Open | |
| 26 Oct 2020 | L-100508802 | Bank of Maharashtra | ₹60 Lakh | Open | |
| 26 Oct 2020 | L-100508803 | Bank of Maharashtra | ₹4.5 Cr | Open | |
| 26 Oct 2020 | L-100508804 | Bank of Maharashtra | ₹3 Cr | Open | |
| 26 Oct 2020 | L-100508806 | Bank of Maharashtra | ₹1.5 Cr | Open |
To see the full charge records of Orbit Pharma Laboratories LLP, buy the company report.
Total charge records: 6 View all charges
Legal cases
Orbit Pharma Laboratories LLP has 10 court cases on record: 10 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 10 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Sudersun Chemical Pvt Ltd. Through Its Chief Managing Director Hitesh Manubhai Shah | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Sudersun Chemical Pvt Ltd. Through Its Chief Managing Director Hitesh Manubhai Shah | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Umiya Enviro Project Llp-Jinalkumar Rameshchandra Patel | Disposed |
| District court, GANDHINAGAR, Gujarat | Court case (SMST S) | Filed against the company by Mr. Siddharth Dineshbhai Shah Authorised Signatory of Valiant Organics Ltd., | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by M/S Navkar Exim Owner of Snehalbhai Shah | Disposed |
To see the full case history of Orbit Pharma Laboratories LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orbit Pharma Laboratories LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Orbit Pharma Laboratories LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orbit Pharma Laboratories LLP has 5 designated partner changes on record since 2020: 4 appointments and 1 cessation. The latest: Rima Kunal Kikani was appointed as Partner on 10 Apr 2024.
4 earlier events are in the company report.
Frequently asked questions
Orbit Pharma Laboratories has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Orbit Pharma Laboratories was a limited liability partnership based in Kalol, Gujarat, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2020 and is registered under LLPIN AAU-4237. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Orbit Pharma Laboratories is AAU-4237. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Orbit Pharma Laboratories had 4 designated partners:
- Naranbhai Parshotambhai Kikani - Designated Partner
- Rima Kunal Kikani - Partner
- Kunal Naranbhai Kikani - Designated Partner
- Smitaben Naranbhai Kikani - Partner
Orbit Pharma Laboratories was incorporated on 26 October 2020. It is registered with the Registrar of Companies, Ahmedabad.
Orbit Pharma Laboratories can be reached through the website orbitpharm.com. Its registered office is in Kalol, Gujarat, India.
The registered office of Orbit Pharma Laboratories is at Block No. 1551 4 159 Chhatral Kadi Road Village Dhanot, Kalol, Gujarat, India – 382729.
The latest financial statements of Orbit Pharma Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2021 are in the company report.
Orbit Pharma Laboratories operated in the pharma industry, in the drug formulation and development segment.
Orbit Pharma Laboratories has 10 court cases on record: 10 filed against it.

